Nasdaq Halts Trading in Moolec Science Ahead of Voluntary Company Liquidation
New York, Monday, 2 November 2026.
With 98.4% shareholder backing, Moolec Science enters voluntary liquidation, prompting Nasdaq to suspend trading on November 3, 2026, and officially delist the early-stage food technology firm.
Moolec Science’s Shareholder-Driven Exit from Public Markets
Moolec Science SA (Nasdaq: MLEC), a molecular farming food-ingredient company, has formally initiated its exit from public markets following overwhelming shareholder support for voluntary liquidation. On October 20, 2026, shareholders voted 98.4 / 100 * 100 = 98.4% in favor of winding up the company and appointing Joint Voluntary Liquidators, as detailed in regulatory filings [5]. The extraordinary general meeting’s outcome underscored the shareholders’ commitment to finalize the liquidation process, which had been under consideration amid persistent challenges in the agritech sector [5]. Alejandro Antalich, the former CEO, and Valeria Falottico, the former CFO, resigned effective immediately following the liquidation approval, transferring all executive powers to the appointed liquidators [5].
Regulatory Delisting and Trading Suspension Timeline
Nasdaq notified Moolec Science of its delisting determination on October 27, 2026, pursuant to Listing Rules 5101, 5110(b), and IM-5101-1 [1]. The decision was based on the company’s voluntary winding-up and associated public interest considerations, including residual equity interests and compliance with continued listing requirements [1]. Trading in MLEC shares will be suspended at the opening of business on November 3, 2026, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to effectuate the delisting [1]. The suspension marks the formal end of Moolec Science’s public trading journey, which had been marked by significant volatility and declining market confidence [8].
Market Performance and Investor Sentiment Leading to Liquidation
Moolec Science’s stock performance reflected the growing investor skepticism toward the company’s long-term viability. On October 30, 2026, MLEC shares closed at $1.40, a 1.40 - 1.35 = 0.05 or 3.70% increase from the day’s low of $1.35, but still representing a steep decline from its peak [8]. The stock had been classified as a sell candidate since September 15, 2026, with a cumulative loss of 78.88 / 100 * 100 = 78.88% [8]. Technical analysis tools rated MLEC at -4.654 on a -10 to +10 scale, further reinforcing the bearish sentiment [8]. The company’s struggles were emblematic of broader challenges faced by early-stage agritech ventures in 2026, as investor appetite waned in the face of prolonged market headwinds [GPT].
Implications of Liquidation for Stakeholders
The liquidation process will prioritize the orderly distribution of remaining assets to creditors and shareholders, with the Joint Voluntary Liquidators—Cassandra Ronaldson and Amiel Gottlieb—overseeing the proceedings [1][5]. Shareholders, who overwhelmingly approved the liquidation, will receive residual value based on the company’s asset liquidation proceeds, though the exact quantum remains undetermined at this stage [5]. The delisting from Nasdaq will eliminate MLEC from public equity markets, leaving investors to navigate the aftermath through alternative channels or private settlements [1]. For the agritech sector, Moolec Science’s exit serves as a cautionary tale of the challenges facing early-stage food technology companies amid tightening capital markets and investor scrutiny [GPT].